Ali Mohamed Hassan, Eltobgy Ahmed, Ismail Iman Yehia, Ghobish Ammar
Department of Urology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Urol Ann. 2020 Oct-Dec;12(4):341-346. doi: 10.4103/UA.UA_138_19. Epub 2020 Oct 15.
The purpose of the study is to assess the quality of transurethral resection of bladder tumors (TURBTs) performed by "senior" and "junior" urologists in terms of detrusor muscle (DM) presence at the initial resection and presence of missed and residual tumors at second-look TURBT.
An analytic prospective cohort study included 171 patients with stage T1 and Ta bladder cancer who had undergone an initial TURBT. Patients were divided into two groups according to surgeon experience. Group 1 (116 patients) operated on by senior surgeons (consultants and trainees in year 5 or 6) and Group 2 (55 patients) operated on by junior surgeons (trainees below year 5). All patients underwent second-look TURBT (by a senior urologist) within 2-6 weeks after the initial resection. The outcome of the initial and re-TURBT represented with regard to the surgeon experience.
There is a statistically significant difference between senior and junior surgeons regarding the presence or absence of DM in the initial resection ( = 0.001). A significant relation between the presence of residual tumors in re thermodynamic uncertainty relation (TUR) in relation to the initial operator was found ( = 0.03). Re-TURBT of patients in Group 1 (initially operated on by experienced surgeons) revealed that 57.7% had tumor-free resection while 36.2% had residual tumors, 5.2% had missed lesion and only 0.9% had concurrent residual and missed tumors. In contrast, from Group 2 (55 patients operated by junior surgeons) 47.3% had residual tumor, 21.8% had missed lesions, and 9.1% had concurrent residual and missed tumors in re-TUR.
Nonmuscle invasive bladder cancer treated with TURBT should be managed as any other major oncologic procedure. TURBT should be performed by an experienced surgeon or with very close supervision when done by training urologist.
本研究旨在评估“资深”和“初级”泌尿外科医生进行经尿道膀胱肿瘤切除术(TURBT)的质量,评估指标包括初次切除时逼尿肌(DM)的存在情况以及二次经尿道膀胱肿瘤切除术时漏诊和残留肿瘤的情况。
一项分析性前瞻性队列研究纳入了171例T1期和Ta期膀胱癌患者,这些患者均接受了初次TURBT。根据外科医生的经验将患者分为两组。第1组(116例患者)由资深外科医生(顾问医生以及第5或6年的实习医生)进行手术,第2组(55例患者)由初级外科医生(第5年以下的实习医生)进行手术。所有患者在初次切除术后2 - 6周内接受二次经尿道膀胱肿瘤切除术(由资深泌尿外科医生进行)。根据外科医生的经验呈现初次和再次TURBT的结果。
资深和初级外科医生在初次切除时DM的有无方面存在统计学显著差异(P = 0.001)。发现再次经尿道膀胱肿瘤切除术(TUR)中残留肿瘤的存在与初次手术医生之间存在显著关联(P = 0.03)。第1组(最初由经验丰富的外科医生进行手术)患者的再次TURBT显示,57.7%的患者切除无肿瘤,36.2%有残留肿瘤,5.2%有漏诊病变,仅有0.9%同时存在残留和漏诊肿瘤。相比之下,第2组(55例由初级外科医生进行手术的患者)在再次TUR中,47.3%有残留肿瘤,21.8%有漏诊病变,9.1%同时存在残留和漏诊肿瘤。
采用TURBT治疗的非肌层浸润性膀胱癌应如同其他重大肿瘤手术一样进行管理。TURBT应由经验丰富的外科医生进行,或者在泌尿外科实习医生进行手术时进行非常密切的监督。